Table 6.
Risk Prediction Model.
| Predictors | IDI | NRI | ΔAUC | Δ-2log Likelihood |
|---|---|---|---|---|
| Hypertension | 0.02 (−0.06–0.1) | 0.35 (−0.8–0.7) | 0.02 ± 0.07 | 2.81 |
| Type 2 Diabetes Mellitus | −0.03 (−0.2–0.1) | −0.49 (−1.2–0.9) | 0.02 ± 0.07 | 1.28 |
| Coronary Artery Disease | 0.01 (−0.02–0.1) | 0.05 (−0.6–0.4) | 0.04 ± 0.07 | 2.93 |
| Congestive Heart Failure | 0.04 (−0.02–0.1) | 0.15 (−0.6–0.8) | 0.06 ± 0.07 | 11.8** |
| Chronic Kidney Disease | 0.02 (−0.05–0.1) | 0.49 (−1.5–1.0) | 0.04 ± 0.07 | 4.02* |
| Acute Kidney Injury | 0.01 (−0.01–0.05) | 0.02 (−0.75–0.8) | 0.01 ± 0.07 | 2.2 |
| Stroke | 0.01 (−0.03–0.05) | −0.56 (−1.2–0.6) | 0.03 ± 0.07 | 4.15* |
| Methylprednisolone | 0.03 (−0.04–0.2) | 0.32 (−0.7–1.0) | 0.04 ± 0.07 | 2.41 |
| Dexamethasone | 0.16 (0.01–0.5)* | 0.64 (0.0–1.6)* | 0.16 ± 0.07* | 16.30** |
| Hydroxychloroquine | 0.11 (−0.08–0.5) | 0.41 (−0.3–1.5) | 0.17 ± 0.07* | 16.31** |
| Azithromycin | 0.14 (−0.2–0.4) | 0.31 (−0.76–0.9) | 0.11 ± 0.07 | 15.18** |
Note: ΔAUC and Δ-2logLikelihood indicates change in the statistic after the addition of the corresponding independent variable in the model. ** & * indicates P-value < 0.01 and < 0.05 respectively.